Clinical Trials Browser

Phase 1/2 × Paraganglioma × Magnetic Resonance Spectroscopy × Clear all

NCT02177773 2019-11-12

DOTA-TOC

Phase 1/2 Terminated

300 enrolled 5 charts

CNSEndocrineNET

Carcinoid Tumor, Neuroblastoma, Paraganglioma, Neuroendocrine Tumors